Abstract: An electrolyte injection device for a battery cell according to one example includes a transfer member provided to be transferable along a first direction, a base member, which is disposed on the transfer member, for mounting at least one battery cell, an injection part for injecting an electrolyte into the battery cell located on the base member, and a clamping unit provided on the base member and provided to clamp both sides of the battery cell along the first direction.

Abstract: A position roller for meander control includes, in one example, a roller with a rotational axis; a first ball joint supporting a distal end among both ends of the rotational axis for pivotal movement; an XZ driver that drives a proximal end among both ends of the rotational axis into two-dimensional motion in a plane; and a base supporting the first ball joint and the XZ driver.

Abstract: An asymmetric fusion protein in which a fragment of an antibody binding to an insulin receptor, an iduronate-2-sulfatase (IDS) enzyme, and an Fc region are fused, and a use thereof are disclosed. The fusion protein can cross the blood-brain barrier (BBB) to deliver the IDS enzyme to the brain. Therefore, a pharmaceutical composition containing the fusion protein as an active ingredient can be used as a therapeutic agent for a central nervous system disease and particularly, is expected to prevent and treat various diseases caused by ribosome accumulation.

Abstract: The present invention provides a linear evaporation source which receives heat from a crucible such that heat is uniformly distributed while a uniform heat distribution cover is seated on an accommodation case. The provided linear evaporation source includes an accommodation case forming an accommodation space with an open upper side, a crucible accommodated in the accommodation space and configured to discharge a deposition material, and a uniform heat distribution cover configured to cover the accommodation case to uniformly distribute a temperature by receiving heat from the crucible.

Abstract: The present invention provides a linear evaporation source which receives heat from a crucible such that heat is uniformly distributed while a uniform heat distribution cover is seated on an accommodation case. The provided linear evaporation source includes an accommodation case forming an accommodation space with an open upper side, a crucible accommodated in the accommodation space and configured to discharge a deposition material, and a uniform heat distribution cover configured to cover the accommodation case to uniformly distribute a temperature by receiving heat from the crucible.

Abstract: An anti-CD3 antibody and a pharmaceutical composition, and their uses are disclosed. The anti-CD3 antibody are useful for treating or preventing cancer. The antibody has high affinity and specificity for CD3 and thus can be effectively used in cancer prevention or treatment.

Abstract: Disclosed is an entropy generation apparatus, which includes a detector that detects particles emitted from the radiation source to generate a detection signal; a preamplifier that amplifies the detection signal to generate an amplified signal; a filter that filters the amplified signal to generate a filtered signal; and a comparator that generates a pulse based on a result of comparing the filtered signal with a threshold value.

Abstract: The present invention relates to an anti-CD3 antibody and a pharmaceutical composition for cancer treatment comprising same. The antibody according to the present invention has high affinity and specificity for CD3 and thus can be effectively used in cancer prevention or treatment.

Abstract: The present invention relates to an anti-MSLN antibody and a pharmaceutical composition for cancer treatment comprising same. The anti-MSLN antibody according to the present invention has high affinity and specificity for MSLN and thus can be effectively used in cancer prevention or treatment.

Abstract: An asymmetric fusion protein in which a fragment of an antibody binding to an insulin receptor, an iduronate-2-sulfatase (IDS) enzyme, and an Fc region are fused, and a use thereof are disclosed. The fusion protein can cross the blood-brain barrier (BBB) to deliver the IDS enzyme to the brain. Therefore, a pharmaceutical composition containing the fusion protein as an active ingredient can be used as a therapeutic agent for a central nervous system disease and particularly, is expected to prevent and treat various diseases caused by ribosome accumulation.

Abstract: A door glass assembly is configured to reduce an impact noise generated when a door glass is moved upward/downward and may include a carrier plate coupled to a glass holder to which a door glass of a vehicle is secured. The carrier plate is installed inside a door of the vehicle so as to be movable upward/downward. A module plate, on which the carrier plate is installed so as to be movable upward/downward, is installed inside the door of the vehicle. A driving motor is provided to move the carrier plate upward/downward. The module plate and the carrier plate are provided with an impact noise preventing means for gradually decelerating and stopping the carrier plate when the door glass is being maximally moved upward or downward.

Abstract: The present invention relates to an anti-CD3 antibody and a pharmaceutical composition for cancer treatment comprising same. The antibody according to the present invention has high affinity and specificity for CD3 and thus can be effectively used in cancer prevention or treatment.

Abstract: The present invention relates to an anti-MSLN antibody and a pharmaceutical composition for cancer treatment comprising same. The anti-MSLN antibody according to the present invention has high affinity and specificity for MSLN and thus can be effectively used in cancer prevention or treatment.

Abstract: A door glass assembly is configured to reduce an impact noise generated when a door glass is moved upward/downward and may include a carrier plate coupled to a glass holder to which a door glass of a vehicle is secured. The carrier plate is installed inside a door of the vehicle so as to be movable upward/downward. A module plate, on which the carrier plate is installed so as to be movable upward/downward, is installed inside the door of the vehicle. A driving motor is provided to move the carrier plate upward/downward. The module plate and the carrier plate are provided with an impact noise preventing means for gradually decelerating and stopping the carrier plate when the door glass is being maximally moved upward or downward.

Abstract: Disclosed are a pulse radar apparatus and an operating method of the pulse radar apparatus, the pulse radar apparatus including a transmitter configured to receive a reference signal as a transmission clock signal, and transmit a transmission pulse to an object based on the transmission clock signal, a negative feedback loop configured to delay the reference signal and output the delayed reference signal as a reception clock signal, and a receiver configured to restore, based on the reception clock signal, a reflection pulse received in response to the transmission pulse being reflected from the object, wherein the negative feedback loop is configured to generate a delay control signal using the reference signal and a predetermined waveform signal generated by a waveform generator, delay the reference signal based on the delay control signal, and adjust the delay control signal by controlling the waveform generator to change the predetermined waveform signal.

Abstract: Disclosed are a pulse radar apparatus and an operating method of the pulse radar apparatus, the pulse radar apparatus including a transmitter configured to receive a reference signal as a transmission clock signal, and transmit a transmission pulse to an object based on the transmission clock signal, a negative feedback loop configured to delay the reference signal and output the delayed reference signal as a reception clock signal, and a receiver configured to restore, based on the reception clock signal, a reflection pulse received in response to the transmission pulse being reflected from the object, wherein the negative feedback loop is configured to generate a delay control signal using the reference signal and a predetermined waveform signal generated by a waveform generator, delay the reference signal based on the delay control signal, and adjust the delay control signal by controlling the waveform generator to change the predetermined waveform signal.

Abstract: A bandpass filter that provides a wide gain control range is provided. The bandpass filter performs channel filtering and gain control while maintaining the bandpass characteristic of the bandpass filter. The bandpass filter enables gain control for a wide signal amplitude range while maintaining performance characteristics, such as an out-of-band attenuation ratio capable of high linearity and good pass-band flatness.

Abstract: A bandpass filter that provides a wide gain control range is provided. The bandpass filter performs channel filtering and gain control while maintaining the bandpass characteristic of the bandpass filter. The bandpass filter enables gain control for a wide signal amplitude range while maintaining performance characteristics, such as an out-of-band attenuation ratio capable of high linearity and good pass-band flatness.

Abstract: The present invention relates to a drug delivery composition comprising a hyaluronic acid-peptide conjugate micelle and a production method thereof. According to the drug delivery composition and the production method of the drug-loaded, hyaluronic acid-peptide conjugate micelle of the present invention, the reaction for encapsulating can proceed in a mixed solvent of an aqueous solvent and an organic solvent. Therefore, the present invention can be applied to various types of water-insoluble active components and the biocompatible and biodegradable derivative can encapsulate a drug to provide a drug-loaded micelle, which is safe to be applied for human bodies. Moreover, the micelle has a therapeutic effect from the peptide contained therein, which can act in combination with the drug as packing therein. Therefore, the drug delivery composition and its production method can be utilized in the field of producing a sustained release formulation with an extended duration of the medicinal effect.

Abstract: The present invention relates to a composition for nucleic acid delivery and a method for preparing the same, more particularly to a composition for nucleic acid delivery having excellent stability in the body environment and excellent intracellular delivery efficiency of nucleic acid, and enabling target directed delivery of nucleic acid, and a method for preparing the same.